These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8676599)

  • 1. [Long-term ursodeoxycholic acid treatment of cholestatic liver diseases in childhood--clinical and biochemical effects].
    Kardorff R; Melter M; Rodeck B; Brodehl J
    Klin Padiatr; 1996; 208(3):118-22. PubMed ID: 8676599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience.
    Zapata R; Sandoval L; Palma J; Hernández I; Ribalta J; Reyes H; Sedano M; Tohá D; Silva JJ
    Liver Int; 2005 Jun; 25(3):548-54. PubMed ID: 15910492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia.
    Willot S; Uhlen S; Michaud L; Briand G; Bonnevalle M; Sfeir R; Gottrand F
    Pediatrics; 2008 Dec; 122(6):e1236-41. PubMed ID: 19029197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
    Lebensztejn DM
    Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary sclerosing cholangitis: conventional and quantitative liver function tests during long-term therapy with ursodeoxycholic acid].
    Schönfeld J; Zotz R; Mahl M; Beste M; Breuer N; Goebell H
    Z Gastroenterol; 1996 Feb; 34(2):123-7. PubMed ID: 8659187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
    Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of pruritus in primary biliary cirrhosis.
    Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
    Lykavieris P; Ducot B; Lachaux A; Dabadie A; Broué P; Sarles J; Bernard O; Jacquemin E
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):623-9. PubMed ID: 18955864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
    Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
    Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.
    Arat M; Idilman R; Soydan EA; Soykan I; Erden E; Karayalçin S; Akan H
    Clin Transplant; 2005 Dec; 19(6):798-803. PubMed ID: 16313328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice.
    Treeprasertsuk S; Silachamroon U; Krudsood S; Huntrup A; Suwannakudt P; Vannaphan S; Wilairatana P
    J Gastroenterol Hepatol; 2010 Feb; 25(2):362-8. PubMed ID: 19817958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of cholestatic liver diseases; the role of ursodeoxycholic acid].
    Stiehl A
    Z Gastroenterol; 1992 Oct; 30(10):743-7. PubMed ID: 1441678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [-Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-].
    Rudi J; Schönig T; Stremmel W
    Z Gastroenterol; 1996 Mar; 34(3):188-91. PubMed ID: 8650973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic therapy with ursodeoxycholic acid in a child with Alagille syndrome].
    Clerici C; Gentili G; Dozzini G; Distrutti E; Solinas A; Vedovelli A; Pelli MA; Bragetti P; Setchell K; Morelli A
    Pediatr Med Chir; 1993; 15(5):521-3. PubMed ID: 8159589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bile acids in liver diseases--current indications].
    Stiehl A
    Ther Umsch; 1995 Oct; 52(10):682-6. PubMed ID: 7482380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.